Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia
- 20 September 2009
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 47 (2-3) , 420-425
- https://doi.org/10.1016/j.molimm.2009.08.023
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI50089, AI64414)
This publication has 38 references indexed in Scilit:
- LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidneyJournal of Lipid Research, 2008
- Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB ActivationMolecular and Cellular Biology, 2008
- Cellular energetic metabolism in sepsis: The need for a systems approachBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cellsMetabolism, 2007
- Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 2005
- Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathwaysKidney International, 2005
- Linking stress to immunity?Nature Immunology, 2005
- Different ways to regulate the PPARα stabilityBiochemical and Biophysical Research Communications, 2004
- The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent LiverJournal of Biological Chemistry, 2000
- Effect of Endotoxin and Platelet-activating Factor on Lipid Oxidation in the Rat HeartJournal of Molecular and Cellular Cardiology, 1997